A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China (vol 11, 574562, 2020)

被引：0
作者：
Zhang, N.
Shi, N.
Li, S.
Liu, G.
Han, Y.
Liu, L.
Zhang, X.
Kong, X.
Zhang, B.
Yuan, W.
Liu, Y.
Deng, D.
Zheng, M.
Zhang, Y.
Li, L.
Wang, X.
Wu, J.
Lin, X.
Nian, H.
Wu, X.
Wang, H.
Liu, F.
Zeng, W.
Yang, M.
Wang, Y.
Zhai, H.
机构：
来源：
FRONTIERS IN PHARMACOLOGY | 2021年 / 12卷
基金：
国家重点研发计划;
关键词：
Chinese patent medicine; COVID-19; application regularity; correlative factor; retrospective analysis;
D O I：
10.3389/fphar.2021.654045
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：1
相关论文
共 1 条
  • [1] A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
    Zhang, Nan
    Shi, Nannan
    Li, Siyu
    Liu, Guoxiu
    Han, Yonglong
    Liu, Li
    Zhang, Xin
    Kong, Xiangwen
    Zhang, Bihua
    Yuan, Wenpeng
    Liu, Yi
    Deng, Deqiang
    Zheng, Minxia
    Zhang, Ying
    Li, Lihua
    Wang, Xiaoping
    Wu, Jiankun
    Lin, Xiaolan
    Nian, Hua
    Wu, Xiaohong
    Wang, Hua
    Liu, Fang
    Wang, Hongli
    Wang, Hongshun
    Liu, Ying
    Zeng, Weixin
    Yang, Manqin
    Wang, Yanping
    Zhai, Huaqiang
    Wang, Yongyan
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
1